{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:22:39Z","timestamp":1791613359555,"version":"4.3.4"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T00:00:00Z","timestamp":1639612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST-110-2628-B-037-010"],"award-info":[{"award-number":["MOST-110-2628-B-037-010"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004694","name":"Kaohsiung Medical University","doi-asserted-by":"publisher","award":["KMU-DK(B)110006, KMU-KI110004, NSYSUKMU 110-I002"],"award-info":[{"award-number":["KMU-DK(B)110006, KMU-KI110004, NSYSUKMU 110-I002"]}],"id":[{"id":"10.13039\/501100004694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015045","name":"Kaohsiung Armed Forces General Hospital","doi-asserted-by":"publisher","award":["802KB109388"],"award-info":[{"award-number":["802KB109388"]}],"id":[{"id":"10.13039\/501100015045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Fibrinogen-like protein 1 (FGL1) was recently identified as a major ligand of lymphocyte-activation gene-3 (LAG-3) on activated T cells and serves as an immune suppressive molecule for regulation of immune homeostasis. However, whether FGL1 has therapeutic potential for use in the T cell-induced the autoimmune disease, rheumatoid arthritis (RA), is still unknown. Here, we attempted to evaluate the effect of FGL1 protein on arthritis progression. We also evaluated potential adverse events in a collagen-induced arthritis (CIA) mouse model. We first confirmed that soluble Fgl1 protein could specifically bind to surface Lag-3 receptor on 3T3-Lag-3 cells and further inhibit interleukin (IL-2) and interferon gamma (IFN\u03b3) secretion from activated primary mouse T cells by 95% and 43%, respectively. Intraperitoneal administration of Fgl1 protein significantly decreased the inflammatory cytokine level (i.e., IL-1\u03b2 and IL-6) in local paw tissue, and prevented joint inflammation, cellular infiltration, bone deformation and attenuated collagen-induced arthritis progression\n                    <jats:italic>in vivo<\/jats:italic>\n                    . We further demonstrated that exogenous Fgl1 does not cause obvious adverse events during treatment by monitoring body weight and liver weight, and assessing the morphology of several organs (i.e., heart, liver, spleen, lung and kidney) by pathological studies. We expect that Fgl1 protein may be suitable to serve as a potential therapeutic agent for treatment of RA or even other types of T cell-induced autoimmune or inflammatory diseases in the future.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2021.767868","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T07:30:13Z","timestamp":1639639813000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Fibrinogen-Like Protein 1 Serves as an Anti-Inflammatory Agent for Collagen-Induced Arthritis Therapy in Mice"],"prefix":"10.3389","volume":"12","author":[{"given":"Wen-Wei","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Wen","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Han","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shey-Cherng","family":"Tzou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Ju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Chi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Shen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Chen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En-Shuo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Cheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Tseng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Lu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid Arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00353","article-title":"Effector Functions of CD4+ T Cells at the Site of Local Autoimmune Inflammation-Lessons From Rheumatoid Arthritis","volume":"10","author":"Chemin","year":"2019","journal-title":"Front Immunol"},{"key":"B3","article-title":"Rheumatoid Arthritis: Common Questions About Diagnosis and Management","volume":"97","author":"Wasserman","year":"2018","journal-title":"Am Fam Physician"},{"key":"B4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/ar2107","article-title":"Cells of the Synovium in Rheumatoid Arthritis. T Lymphocytes","volume":"9","author":"Lundy","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar2412","article-title":"T Cells in Rheumatoid Arthritis","author":"Cope","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2011.04.034","article-title":"Effector T Cells in Rheumatoid Arthritis: Lessons From Animal Models","volume":"585","author":"Alzabin","year":"2011","journal-title":"FEBS Lett"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780351209","article-title":"Rheumatoid Synovium is Enriched in CD45RBdim Mature Memory T Cells That Are Potent Helpers for B Cell Differentiation","volume":"35","author":"Thomas","year":"1992","journal-title":"Arthritis Rheum"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200612","article-title":"Inflamed Target Tissue Provides a Specific Niche for Highly Expanded T-Cell Clones in Early Human Autoimmune Disease","volume":"71","author":"Klarenbeek","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5703","article-title":"IL-17 in Synovial Fluids From Patients With Rheumatoid Arthritis Is a Potent Stimulator of Osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J Clin Invest"},{"key":"B10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/ar4325","article-title":"Role of Neutrophils in Systemic Autoimmune Diseases","volume":"15","author":"Kaplan","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.03.003","article-title":"Autoantibodies in Inflammatory Arthritis","volume":"15","author":"Conigliaro","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2014.04.013","article-title":"Hepassocin Activates the EGFR\/ERK Cascade and Induces Proliferation of L02 Cells Through the Src-Dependent Pathway","volume":"26","author":"Gao","year":"2014","journal-title":"Cell Signal"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.171124","article-title":"Recombinant Human Hepassocin Stimulates Proliferation of Hepatocytes In Vivo and Improves Survival in Rats With Fulminant Hepatic Failure","volume":"59","author":"Li","year":"2010","journal-title":"Gut"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2009.201020","article-title":"Hepassocin as a Treatment for Fulminant Hepatic Failure: Will it Translate From Rats to Human","volume":"59","author":"Calvaruso","year":"2010","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cell.2018.11.010","article-title":"Fibrinogen-Like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3","volume":"176","author":"Wang","year":"2019","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.56748","article-title":"The Role of Fibrinogen-Like Proteins in Cancer","volume":"17","author":"Yu","year":"2021","journal-title":"Int J Biol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/art.34550","article-title":"Brief Report: Amelioration of Collagen-Induced Arthritis in Mice by Lentivirus-Mediated Silencing of microRNA-223","volume":"64","author":"Li","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B18","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1186\/ar430","article-title":"Anti-TNF-Alpha Antibody Allows Healing of Joint Damage in Polyarthritic Transgenic Mice","volume":"4","author":"Shealy","year":"2002","journal-title":"Arthritis Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/art.20201","article-title":"Modulation of Inflammation and Response to Dexamethasone by Annexin 1 in Antigen-Induced Arthritis","volume":"50","author":"Yang","year":"2004","journal-title":"Arthritis Rheum"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208216","article-title":"Signs of Immune Activation and Local Inflammation are Present in the Bronchial Tissue of Patients With Untreated Early Rheumatoid Arthritis","volume":"75","author":"Reynisdottir","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/iid3.377","article-title":"Animal Models of Rheumatoid Arthritis-Associated Interstitial Lung Disease","volume":"9","author":"Xiong","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2004.08.010","article-title":"Role of LAG-3 in Regulatory T Cells","volume":"21","author":"Huang","year":"2004","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T Cell Exhaustion by Multiple Inhibitory Receptors During Chronic Viral Infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2019.101305","article-title":"Lymphocyte-Activation Gene 3 (LAG3): The Next Immune Checkpoint Receptor","volume":"42","author":"Ruffo","year":"2019","journal-title":"Semin Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.575609","article-title":"Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy","volume":"11","author":"Alfarra","year":"2020","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100714","article-title":"Cutting Edge: Accelerated Autoimmune Diabetes in the Absence of LAG-3","volume":"187","author":"Bettini","year":"2011","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900823","article-title":"A LAG-3-Specific Agonist Antibody for the Treatment of T Cell-Induced Autoimmune Diseases","volume":"204","author":"Angin","year":"2020","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.11.5744","article-title":"Characterization of the Major Histocompatibility Complex Class II Binding Site on LAG-3 Protein","volume":"94","author":"Huard","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0150","article-title":"Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells","volume":"3","author":"Kouo","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2005.12.020","article-title":"Galectin-3: An Open-Ended Story","volume":"1760","author":"Dumic","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-2690","article-title":"LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-Cell Responses","volume":"74","author":"Xu","year":"2014","journal-title":"Cancer Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2008.02118.x","article-title":"Neutralizing IL-21 and IL-15 Inhibits Pro-Inflammatory Cytokine Production in Rheumatoid Arthritis","volume":"68","author":"Andersson","year":"2008","journal-title":"Scand J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(89)90430-3","article-title":"Inhibitory Effect of TNF Alpha Antibodies on Synovial Cell Interleukin-1 Production in Rheumatoid Arthritis","volume":"2","author":"Brennan","year":"1989","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830211039","article-title":"Expression of Granulocyte-Macrophage Colony-Stimulating Factor in Rheumatoid Arthritis: Regulation by Tumor Necrosis Factor-Alpha","volume":"21","author":"Haworth","year":"1991","journal-title":"Eur J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.20.9784","article-title":"Anti-Tumor Necrosis Factor Ameliorates Joint Disease in Murine Collagen-Induced Arthritis","volume":"89","author":"Williams","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"B36","article-title":"Modulation of Proinflammatory Cytokine Release in Rheumatoid Synovial Membrane Cell Cultures. Comparison of Monoclonal Anti TNF-Alpha Antibody With the Interleukin-1 Receptor Antagonist","volume":"6","author":"Butler","year":"1995","journal-title":"Eur Cytokine Netw"},{"key":"B37","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1146\/annurev.immunol.14.1.397","article-title":"Role of Cytokines in Rheumatoid Arthritis","volume":"14","author":"Feldmann","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2017.1295850","article-title":"The Role and Therapeutic Targeting of IL-6 in Rheumatoid Arthritis","volume":"13","author":"Narazaki","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.3390\/ijms21155238","article-title":"Interleukin-6 in Rheumatoid Arthritis","volume":"21","author":"Pandolfi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058084","article-title":"Targeted Deletion of Fibrinogen Like Protein 1 Reveals a Novel Role in Energy Substrate Utilization","volume":"8","author":"Demchev","year":"2013","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13075-020-02169-0","article-title":"Cartilage-Binding Antibodies Initiate Joint Inflammation and Promote Chronic Erosive Arthritis","volume":"22","author":"Li","year":"2020","journal-title":"Arthritis Res Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.767868\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T14:19:36Z","timestamp":1648649976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.767868\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,16]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2021.767868"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.767868","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,16]]},"article-number":"767868"}}